14-Gene Prognostic Assay clinical trials

Adjuvant Chemotherapy in Patients With Intermediate or High Risk Stage I or Stage IIA Non-squamous Non-Small Cell Lung Cancer: AIM-HIGH (Adjuvant Intervention in Molecular High Risk Patients)

This study looks into whether extra chemotherapy after surgery helps people with early-stage non-small cell lung cancer that is considered high risk. It uses a special gene test to identify these patients and compares two ways of looking after them.